Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × Eflornithine × Clear all

NCT00003076 2012-12-19

Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms